Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,843,560
  • Shares Outstanding, K 46,471
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 285 M
  • EBITDA $ 415 M
  • 60-Month Beta 0.28
  • Price/Sales 2.07
  • Price/Cash Flow 8.42
  • Price/Book 3.09

Options Overview Details

View History
  • Implied Volatility 39.06% (+0.63%)
  • Historical Volatility 39.38%
  • IV Percentile 36%
  • IV Rank 26.13%
  • IV High 72.27% on 10/21/25
  • IV Low 27.31% on 12/08/25
  • Expected Move (DTE 26) 19.68 (32.16%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 75
  • Volume Avg (30-Day) 176
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 5,904
  • Open Int (30-Day) 4,984
  • Expected Range 41.51 to 80.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.28
  • Number of Estimates 6
  • High Estimate 1.31
  • Low Estimate 1.26
  • Prior Year 1.24
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.95 +9.37%
on 02/12/26
73.00 -16.18%
on 01/21/26
-8.91 (-12.71%)
since 01/20/26
3-Month
55.95 +9.37%
on 02/12/26
87.32 -29.92%
on 12/10/25
-13.93 (-18.54%)
since 11/20/25
52-Week
47.31 +29.32%
on 09/26/25
87.32 -29.92%
on 12/10/25
-2.26 (-3.56%)
since 02/20/25

Most Recent Stories

More News
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

BOSTON , Feb. 20, 2026 /PRNewswire/ --  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James...

HAE : 61.19 (+0.86%)
5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

HAE : 61.19 (+0.86%)
HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

HAE : 61.19 (+0.86%)
Haemonetics’s (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars

Haemonetics’s (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars

HAE : 61.19 (+0.86%)
Haemonetics: Fiscal Q3 Earnings Snapshot

Haemonetics: Fiscal Q3 Earnings Snapshot

HAE : 61.19 (+0.86%)
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Financial release and supplemental presentation accessible online

HAE : 61.19 (+0.86%)
What To Expect From Haemonetics’s (HAE) Q4 Earnings

What To Expect From Haemonetics’s (HAE) Q4 Earnings

HAE : 61.19 (+0.86%)
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: Haemonetics (NYSE:HAE)

Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: Haemonetics (NYSE:HAE)

HAE : 61.19 (+0.86%)
1 Russell 2000 Stock to Keep an Eye On and 2 Facing Headwinds

1 Russell 2000 Stock to Keep an Eye On and 2 Facing Headwinds

UMBF : 126.85 (+0.58%)
HAE : 61.19 (+0.86%)
HAIN : 0.8540 (-5.55%)
3 Value Stocks with Open Questions

3 Value Stocks with Open Questions

APAM : 41.60 (-0.55%)
F : 14.01 (+1.67%)
HAE : 61.19 (+0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 63.79
2nd Resistance Point 62.89
1st Resistance Point 62.04
Last Price 61.19
1st Support Level 60.29
2nd Support Level 59.40
3rd Support Level 58.54

See More

52-Week High 87.32
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
Last Price 61.19
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar